JAVMA news
Upcoming legislative activity to center on education
With 88 percent of veterinary students borrowing from federal student loan programs, according to the 2016 AVMA & AAVMC Report on the Market for…
AVMA news
VCPR requirements fuel state legislative activity
The issue of whether to establish a veterinarian-client-patient-relationship (VCPR) through an in-person examination or solely electronic means has…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
JAVMA news
50 years later, animal welfare act is a work in progress
The Animal Welfare Act was signed into law in 1966, originally to protect laboratory animals while also regulating animal dealers and the laboratories…
blog
Here’s one promising approach to address rural veterinary shortages
There are veterinarians who want to work in rural areas of America but are unable to do so—for financial reasons. The great news is that legislation…
Animal health advocacy
The AVMA’s advocacy work provides critical support for the work veterinary teams do every day to protect, promote, and advance animal health. Learn…
JAVMA news
Making their voices heard
Nearly 100 veterinarians and veterinary students lobbied Congress this March for student loan debt relief and against a proposed veterinary…
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
JAVMA news
Veterinary leaders change at FDA
Two Food and Drug Administration executives overseeing veterinary medicine are leaving the agency.
AVMA news
FDA concludes first premarket consultation for meat cultured from animal cells
In a historic move, the Food and Drug Administration’s premarket consultation for meat cultured from animal cells brings Upside Foods’ chicken closer…
AVMA news
AVMA CEO addresses workforce trends
Speaking to animal health industry leaders this August, AVMA CEO Dr. Janet Donlin talked about the challenges and opportunities facing the veterinary…
AVMA news
House Committee advances AVMA-backed xylazine language
The Administration announced its national coordinated response on July 11 to fight the deadly combination of illicit xylazine mixed with fentanyl.
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
Momentum continues for AVMA activities
Summits on educational debt and wellness, recommendations from a task force on drug compounding, and economic reports on topics such as pet insurance…